Brief: Gt Biopharma Reports Second Quarter 2026 Financial Results
BRIEF-Gt Biopharma Reports Second Quarter 2026 Financial Results Aug 14 (Reuters) - GT Biopharma Inc GTBP.O:
GT BIOPHARMA REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
GT BIOPHARMA INC - CASH BALANCE AS OF JUNE 30, OF ABOUT $5.1 MILLION ANTICIPATED TO PROVIDE SUFFICIENT CASH RUNWAY THROUGH Q4 2026
Source text: ID:nGNX6JTcNp
Further company coverage: GTBP.O
((Reuters.Briefs@thomsonreuters.com;))